Related Experiment Video
Updated: Jul 4, 2026

12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
14.7K
Exercise Training and Biomarkers of Neuroaxonal Injury in Multiple Sclerosis: Narrative Review
Trevor B Martin1, Noah G Dubose1, Robert W Motl1
1Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL 60612, USA.
Summary
Exercise training shows promise for multiple sclerosis (MS) by potentially modifying disease progression. Research suggests exercise positively impacts neurofilament light chain (NfL) levels, a key biomarker of neuroaxonal injury in MS.
Area of Science:
- Neurology
- Exercise Science
- Biomarker Research
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with increasing interest in exercise training (ET) for its disease-modifying potential.
- ET may influence MS progression markers like relapses, lesions, disability, and cognitive-processing speed (CPS).
- Limited evidence exists on ET's impact on body fluid biomarkers of neuroaxonal injury in MS.
Purpose of the Study:
- To build a rationale for focusing on exercise training and neuroaxonal injury biomarkers in MS.
- To review the association between ET and specific biomarkers: neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP).
Main Methods:
- A narrative review of literature from PubMed, EBSCOhost, and EMBASE databases.
- Analysis of studies reporting on NfL and GFAP levels in MS patients.
- Inclusion of two meta-analyses specifically examining ET effects on sNfL and sGFAP in MS.
Main Results:
- Serum NfL (sNfL) and GFAP (sGFAP) levels are elevated in MS compared to controls.
- Biomarker levels vary with demographic and clinical factors and respond to disease-modifying therapies.
- Meta-analyses revealed significant positive effects of ET on sNfL, but not sGFAP, in MS.
Conclusions:
- Exercise training demonstrates potential disease-modifying effects in MS, particularly influencing sNfL.
- Future research should utilize discovery models and experimental medicine frameworks for ET and neuroaxonal injury biomarker trials in MS.

